Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Bailong Chuangyuan Bio-tech is a leading Chinese biotechnology company specializing in the research, development, and large-scale production of functional food ingredients, including prebiotics, dietary fibers, and sugar substitutes. The company is recognized as one of the world's largest producers of allulose, polydextrose, and isomalto-oligosaccharide. Their products are widely utilized in the global food, beverage, and healthcare industries to promote digestive health and manage metabolic conditions such as diabetes and obesity. Headquartered in Dezhou, Shandong, the company leverages advanced enzymatic engineering and fermentation technologies for manufacturing. Bailong Chuangyuan is publicly traded on the Shanghai Stock Exchange and maintains a significant international export footprint.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Bailong.